News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Harrison Rosemary
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
4
| Harrison Rosemary (Chief Business & Strategy) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 76,930 options to buy
@ $0.97, valued at
$74.6k
Disposed/sold 12,822 restricted stock units
@ $0
Disposed/sold 191,102 options to buy
@ $4.04, valued at
$772.1k
|
|
| 12/19/2022 |
4
| Harrison Rosemary (Chief Business & Strategy) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 76,930 options to buy
@ $0.97, valued at
$74.6k
Granted 12,822 options to buy
@ $0 |
|
| 01/12/2022 |
4
| Harrison Rosemary (Chief Business & Strategy) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 191,102 options to buy
@ $4.04, valued at
$772.1k
|
|
| 01/12/2022 |
3
| Harrison Rosemary (Chief Business & Strategy) has filed a Form 3 on TCR2 THERAPEUTICS INC. |
| 11/19/2021 |
4
| Harrison Rosemary (See Remarks) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 75 shares
@ $0
Disposed/sold 180,000 options to buy
@ $14.11, valued at
$2.5M
|
|
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|